"Nucleocapsid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A protein-nucleic acid complex which forms part or all of a virion. It consists of a CAPSID plus enclosed nucleic acid. Depending on the virus, the nucleocapsid may correspond to a naked core or be surrounded by a membranous envelope.
Below are MeSH descriptors whose meaning is more general than "Nucleocapsid".
Below are MeSH descriptors whose meaning is more specific than "Nucleocapsid".
This graph shows the total number of publications written about "Nucleocapsid" by people in Harvard Catalyst Profiles by year, and whether "Nucleocapsid" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 1 | 2 |
| 1999 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 1 | 2 | 3 |
| 2008 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 0 | 2 | 2 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 3 | 3 |
| 2022 | 0 | 7 | 7 |
| 2023 | 0 | 2 | 2 |
| 2024 | 1 | 1 | 2 |
Below are the most recent publications written about "Nucleocapsid" by people in Profiles.
-
Identification of mouse CD4+ T cell epitopes in SARS-CoV-2 BA.1 spike and nucleocapsid for use in peptide:MHCII tetramers. Front Immunol. 2024; 15:1329846.
-
Helical reconstruction of VP39 reveals principles for baculovirus nucleocapsid assembly. Nat Commun. 2024 Jan 04; 15(1):250.
-
Development of an Affordable ELISA Targeting the SARS-CoV-2 Nucleocapsid and Its Application to Samples from the Ongoing COVID-19 Epidemic in Ghana. Mol Diagn Ther. 2023 09; 27(5):583-592.
-
Diagnostic TR-FRET assays for detection of antibodies in patient samples. Cell Rep Methods. 2023 03 27; 3(3):100421.
-
SARS-CoV-2 infected children form early immune memory responses dominated by nucleocapsid-specific CD8+ T cells and antibodies. Front Immunol. 2022; 13:1033364.
-
Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection. J Infect Dis. 2022 11 01; 226(9):1577-1587.
-
Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication. Sci Signal. 2022 Oct 25; 15(757):eabm0808.
-
Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy. Cell Rep Med. 2022 11 15; 3(11):100811.
-
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19. Ann Intern Med. 2022 10; 175(10):1401-1410.
-
Longitudinal SARS-CoV-2 Nucleocapsid Antibody Kinetics, Seroreversion, and Implications for Seroepidemiologic Studies. Emerg Infect Dis. 2022 09; 28(9):1859-1862.